TECHNOLOGYEURACTIV
Raising €100m for research in Europe is still very challenging, warns biotech chief [Advocacy Lab]
A Belgian life sciences leader warns that raising €100m for research in Europe remains challenging. The Biotech Act is highlighted as a potential solution to restore confidence in Europe's biotechnology competitiveness.
Related Signal
Adjacent reporting
- Novo-Backed Biotech Hemab Seeks to Raise $212 Million in US IPO
- STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million
- STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more
- STAT+: The China question is tearing biotech apart
- China's biotech boom alarms Western lawmakers, investors
- STAT+: An AI biotech CEO sets the record straight on AI drug development hype